Xiaping He
Overview
Explore the profile of Xiaping He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
9200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen F, Wang N, Tian X, Su J, Qin Y, He R, et al.
Pharmaceutics
. 2025 Jan;
16(12.
PMID: 39771610
In the original publication [...].
2.
Wang N, Cui J, Sun Z, Chen F, He X
Mol Med Rep
. 2024 Oct;
30(6).
PMID: 39392030
Alzheimer's disease (AD) is a neurodegenerative disorder that impairs learning and memory, with high rates of mortality. Birch bark has been traditionally used in the treatment of various skin ailments....
3.
Parker J, Mullins M, Cheang M, Leung S, Voduc D, Vickery T, et al.
J Clin Oncol
. 2023 Sep;
41(26):4192-4199.
PMID: 37672882
Purpose: To improve on current standards for breast cancer prognosis and prediction of chemotherapy benefit by developing a risk model that incorporates the gene expression-based "intrinsic" subtypes luminal A, luminal...
4.
Chen F, Wang N, Tian X, Su J, Qin Y, He R, et al.
Pharmaceutics
. 2023 Jun;
15(6).
PMID: 37376018
Formaldehyde (FA) has been found to induce major Alzheimer's disease (AD)-like features including cognitive impairment, Aβ deposition, and Tau hyperphosphorylation, suggesting that it may play a significant role in the...
5.
Chen F, Wang N, Tian X, Qin Y, Su J, He R, et al.
Front Aging Neurosci
. 2022 Dec;
14:1057059.
PMID: 36583189
Background: Formaldehyde (FA), a toxic aldehyde, has been shown to be associated with a variety of cognitive disorders, including Alzheimer's disease (AD). There is increasing evidence that FA levels are...
6.
Thennavan A, Garcia-Recio S, Liu S, He X, Perou C
NPJ Breast Cancer
. 2022 Jul;
8(1):83.
PMID: 35851387
Ductal carcinoma in situ (DCIS) of the breast is a non-obligate precursor of Invasive Ductal Carcinoma (IDC) and thus the identification of features that may predict DCIS progression would be...
7.
Xia Y, He X, Renshaw L, Martinez-Perez C, Kay C, Gray M, et al.
Clin Cancer Res
. 2022 Jun;
28(16):3618-3629.
PMID: 35653148
Purpose: Endocrine therapy resistance (ETR) remains the greatest challenge in treating patients with hormone receptor-positive breast cancer. We set out to identify molecular mechanisms underlying ETR through in-depth genomic analysis...
8.
Chen F, Wang N, He X
Front Aging Neurosci
. 2022 May;
14:884367.
PMID: 35615586
Background: Alzheimer's disease (AD) is a common neurodegenerative disease. The pathogenesis is complex and has not been clearly elucidated, and there is no effective treatment. Recent studies have demonstrated that...
9.
Gao Y, Kabotyanski E, Shepherd J, Villegas E, Acosta D, Hamor C, et al.
Cancer Res Commun
. 2022 Feb;
1(3):178-193.
PMID: 35156101
Polo-like kinase (PLK) family members play important roles in cell cycle regulation. The founding member PLK1 is oncogenic and preclinically validated as a cancer therapeutic target. Paradoxically, frequent loss of...
10.
Truong A, Zhou M, Krishnan B, Utsumi T, Manocha U, Stewart K, et al.
J Clin Invest
. 2021 Aug;
131(16).
PMID: 34396985
Although immune-checkpoint inhibitors (ICIs) have been a remarkable advancement in bladder cancer treatment, the response rate to single-agent ICIs remains suboptimal. There has been substantial interest in the use of...